Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation... see more

OTCPK:GBGPF - Post Discussion

GB Group Ord Shs > Comparing Cannabis Stock prices
View:
Post by MartialArts on Jan 23, 2018 1:18am

Comparing Cannabis Stock prices

I must say I'm surprised that so many stockhouse investors miss an important concept when comparing share prices between company peers in the same sector.  I don't know if this is cannabis related or a wider problem?

Please don't compare shares prices without looking at market cap and issued shares.  You need to look at market cap and divide the number of issued shares.

Let's start with the factual valuation:

WEED $7.17B  split into 191.81M shares
ACB $6.56B split into 452.73M shares
CMED $923.34M split into  24.43M shares
HIP $854.02M split into 389.70M shares

So let's assume that these four companies had the same number of issues shares you could buy, Say 100M shares to evaluate on the same metric

Weed would be $71.70 per share
ACB would be $65.60 per share
CMED would be $9.34 per share
HIP would be $8.54 per share

You need to put them on an equal issued share value.  If anyone has any questions on this, please message me.  I'm told this is a futile effort but I'm not giving up just yet.
Comment by Metalhead99 on Jan 23, 2018 3:01am
Probably futile, yes, but keep trying, if you have the time and the patience. 
Comment by Duxing on Jan 23, 2018 6:18am
Don’t waste your time! A real investor does not need it. Explaining this to or educating a person only with  elementary education is a waste of time! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities